共 42 条
- [22] Letter by Padfield et al regarding article, "Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 (Atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) study" CIRCULATION, 2007, 115 (15) : E403 - E403
- [25] CORRELATION OF C-REACTIVE PROTEIN LEVELS AND PLATELET REACTIVITY TO OCCURRENCE OF PERI-PROCEDURAL MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PCI: RESULTS OF THE ARMYDA-CRP (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY-C REACTIVE PROTEIN) PROSPECTIVE STUDY JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1924 - E1924
- [26] Response to Letters Regarding Article, "Ischemic Postconditioning During Primary Percutaneous Coronary Intervention: The Effects of Postconditioning on Myocardial Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction (POST) Randomized Trial" CIRCULATION, 2014, 130 (06) : E54 - E55
- [28] Letter by Shroff and Orlandi regarding article, "Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 (Atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) study" CIRCULATION, 2007, 115 (15) : E404 - E404
- [30] Response by Pasupathy et al to Letters Regarding Article, "Early Use of N-acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Infarct Size (The NACIAM Trial [N-Acetylcysteine in Acute Myocardial Infarction])" CIRCULATION, 2018, 137 (13) : 1424 - 1425